Sonnet Biotherapeutics Holdings Inc banner

Sonnet Biotherapeutics Holdings Inc
NASDAQ:SONN

Watchlist Manager
Sonnet Biotherapeutics Holdings Inc Logo
Sonnet Biotherapeutics Holdings Inc
NASDAQ:SONN
Watchlist
Price: 1.26 USD -59.35% Market Closed
Market Cap: $8.9m

Wall St Price Targets

SONN Price Targets Summary
Sonnet Biotherapeutics Holdings Inc

There are no price targets for SONN.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Sonnet Biotherapeutics Holdings Inc Competitors:
Price Targets
VAC
Pierre et Vacances SA
15% Upside
TTD
Trade Desk Inc
104% Upside

Revenue
Forecast

-66% / Year
Past Growth
5 384% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-66% / Year
Past Growth
5 384% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 3 years, the compound annual growth rate for Revenue has been -66%. The projected CAGR for the next 1 year is 5 384%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Sonnet Biotherapeutics Holdings Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is SONN's stock price target?
Not Available

SONN does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Sonnet Biotherapeutics Holdings Inc?
Projected CAGR
5 384%

Over the last 3 years, the compound annual growth rate for Revenue has been -66%. The projected CAGR for the next 1 year is 5 384%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett